Landec Corporation (LNDC) News

Landec Corporation (LNDC): $8.76

-0.32 (-3.52%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add LNDC to Watchlist
Sign Up

Industry: Food Makers


Ranked

of 85

in industry

Filter LNDC News Items

LNDC News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

LNDC News Highlights

  • For LNDC, its 30 day story count is now at 4.
  • Over the past 14 days, the trend for LNDC's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • NOV, HALL and CDMO are the most mentioned tickers in articles about LNDC.

Latest LNDC News From Around the Web

Below are the latest news stories about LANDEC CORP that investors may wish to consider to help them evaluate LNDC as an investment opportunity.

Lifecore Biomedical CEO Hall on Rebranding, New Ticker on Nasdaq

Lifecore Biomedical CEO James G. Hall By Jarrett Banks IPO Edge: Can you give me a short description of what Lifecore does? Lifecore Biomedical is a fully integrated contract development […]

Yahoo | November 15, 2022

Lifecore Biomedical Announces Completion of Corporate Name Change

Common stock expected to begin trading tomorrow under new Nasdaq ticker symbol “LFCR” Lifecore global headquarters relocated to Chaska, MN Launches new investor relations website: ir.lifecore.com CHASKA, Minn., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has completed its transition to Lifecore Biomedical, including the change of its name from La

Yahoo | November 14, 2022

Lifecore Biomedical to Participate in the Stephens Annual Investment Conference on Thursday, November 17, 2022

CHASKA, Minn., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Lifecore” or the “Company”), a diversified health and wellness company with two operating businesses, Lifecore Biomedical, Inc. (“Lifecore”) and Curation Foods, Inc. (“Curation Foods”), – today announced that Jim Hall, CEO of Landec Corporation & President of Lifecore, and John Morberg, CFO will be hosting a fireside chat at the Stephens Annual Investment Conference in Nashville, TN. The Company will participate

Yahoo | November 10, 2022

Landec Expects to Change Corporate Name to Lifecore Biomedical and Ticker Symbol to “LFCR” on November 14

CHASKA, Minn., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Lifecore” or the “Company”) today announced that it expects to effect its previously announced corporate name change to Lifecore Biomedical, Inc. and to cause its common stock to begin trading on Nasdaq under the ticker symbol “LFCR” prior to market open on November 14, 2022. This new ticker symbol will replace the Company’s current ticker symbol “LNDC,” which has been used since its initial public offering in 1

Yahoo | November 1, 2022

Landec: Q1 Earnings Insights

Landec (NASDAQ: LNDC ) reported its Q1 earnings results on Thursday, October 6, 2022 at 07:15 AM. Here''s what investors need to know about the announcement. Earnings Landec missed estimated earnings by 146.15%, reporting an EPS of $-0.32 versus an … Full story available on Benzinga.com

Benzinga | October 6, 2022

Earnings Scheduled For October 6, 2022

Companies Reporting Before The Bell • Conagra Brands (NYSE: CAG ) is likely to report quarterly earnings at $0.52 per share on revenue of $2.85 billion. • Constellation Brands (NYSE: STZ ) is likely to report quarterly earnings at $2.81 per share on revenue of $2.51 billion. • Landec (NASDAQ: LNDC ) is expected to report quarterly loss at $0.13 per share on revenue of $42.74 million. • AngioDynamics (NASDAQ: ANGO ) is likely to report … Full story available on Benzinga.com

Benzinga | October 6, 2022

Landec Corporation Reports First Quarter Fiscal Year 2023 Results

Lifecore segment revenues increased 8.0% to $23.7 million in fiscal 2023 first quarter versus the prior year period Lifecore segment EBITDA increased 8.1% to $2.5 million in fiscal 2023 first quarter versus the prior year period Reiterates fiscal 2023 full year guidance for Lifecore Corporate rebranding to Lifecore Biomedical continues to progress

GlobeNewswire | October 6, 2022

Landec Corporation (LNDC) Q1 2023 Earnings Call Transcript

Landec Corporation (NASDAQ:NASDAQ:LNDC) Q1 2023 Earnings Conference Call October 6, 2022 8:00 AM ET Company Participants Jeff Sonnek - Investor Relations, ICR Jim Hall - Chief Executive…

Seeking Alpha | October 6, 2022

Landec Non-GAAP EPS of -$0.32, revenue of $43.35M (NASDAQ:LNDC)

Landec press release (LNDC): Q1 Non-GAAP EPS of -$0.32.Revenue of $43.35M (+4.1% Y/Y).Lifecore segment revenues increased 8.0% to $23.7 million in fiscal 2023 first quarter versus…

Seeking Alpha | October 6, 2022

Landec (LNDC) Reports Q1 Loss, Tops Revenue Estimates

Landec (LNDC) delivered earnings and revenue surprises of -166.67% and 1.89%, respectively, for the quarter ended August 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | October 6, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5227 seconds.